Unlike genetic mutations, epigenetic modifications do not alter the underlying DNA sequence and can potentially be reversed. This characteristic makes epigenetic changes an attractive target for cancer therapy. For example, demethylating agents can remove methyl groups from DNA, potentially reactivating silenced tumor suppressor genes.
